PDPN+ CAFs facilitate the motility of OSCC cells by inhibiting ferroptosis via transferring exosomal lncRNA FTX

Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN + C...

Full description

Saved in:
Bibliographic Details
Published inCell death & disease Vol. 14; no. 11; pp. 759 - 13
Main Authors Li, Yaoyin, Ma, Zeyi, Li, Weiyu, Xu, Xiaoqing, Shen, Peiqi, Zhang, Si-en, Cheng, Bin, Xia, Juan
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 22.11.2023
Springer Nature B.V
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN + CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN + CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN + CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN + CAFs may serve as a novel potential therapeutic target for OSCC.
AbstractList Abstract Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN+ CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN+ CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN+ CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN+ CAFs may serve as a novel potential therapeutic target for OSCC.
Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN + CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN + CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN + CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN + CAFs may serve as a novel potential therapeutic target for OSCC.
Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN+ CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN+ CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN+ CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN+ CAFs may serve as a novel potential therapeutic target for OSCC.Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN+ CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN+ CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN+ CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN+ CAFs may serve as a novel potential therapeutic target for OSCC.
Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN+ CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN+ CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN+ CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN+ CAFs may serve as a novel potential therapeutic target for OSCC.
Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN CAFs may serve as a novel potential therapeutic target for OSCC.
ArticleNumber 759
Author Zhang, Si-en
Xu, Xiaoqing
Cheng, Bin
Li, Weiyu
Xia, Juan
Ma, Zeyi
Shen, Peiqi
Li, Yaoyin
Author_xml – sequence: 1
  givenname: Yaoyin
  surname: Li
  fullname: Li, Yaoyin
  organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology
– sequence: 2
  givenname: Zeyi
  surname: Ma
  fullname: Ma, Zeyi
  organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology
– sequence: 3
  givenname: Weiyu
  orcidid: 0000-0002-8964-6232
  surname: Li
  fullname: Li, Weiyu
  organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology
– sequence: 4
  givenname: Xiaoqing
  surname: Xu
  fullname: Xu, Xiaoqing
  organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology
– sequence: 5
  givenname: Peiqi
  surname: Shen
  fullname: Shen, Peiqi
  organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology
– sequence: 6
  givenname: Si-en
  surname: Zhang
  fullname: Zhang, Si-en
  organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology
– sequence: 7
  givenname: Bin
  orcidid: 0000-0001-7288-806X
  surname: Cheng
  fullname: Cheng, Bin
  email: chengbin@mail.sysu.edu.cn
  organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology
– sequence: 8
  givenname: Juan
  orcidid: 0000-0002-4966-7119
  surname: Xia
  fullname: Xia, Juan
  email: xiajuan@mail.sysu.edu.cn
  organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37993428$$D View this record in MEDLINE/PubMed
BookMark eNp9kVtrFDEYhoNUbK39A15IwBuhjOY4k7lcRlcLpS1awbuQyaHNMjvZJlnp_nszO7VKL5qbnJ7340ue1-BgDKMF4C1GHzGi4lNimOG2QoRWqCYCVfQFOCKI4YoJ0R78tz4EJymtUBmUIsLrV-CQNm1LGRFHIFx9vro4hd1imaBT2g8-q2xhvrVwHfK03cHg4OWProPaDkOC_Q768db3PvvxBjobY9jkkHyCv72COaoxTYfTpb0PKazVAIdRf79YwOX1rzfgpVNDsicP8zH4ufxy3X2rzi-_nnWL80ozwXPlsEUc9UogUwtqMdasbzSiqHfGtLWhHHPDygUn2jUOOdTWvNGN0YQo0SN6DM7muiaoldxEv1ZxJ4Pycn8Q4o1UMXs9WNkTSgXHzhFDmbNtTwgTRCMsnOF1w0utD3OtTQx3W5uyXPs0fYYabdgmSURLWlbXLSno-yfoKmzjWF66pxgWlDaFevdAbfu1NY_t_dVSADIDOoaUonWPCEZy0i9n_bLol3v9kpaQeBLSk0wfxiLFD89H6RxNm0mcjf_afib1BwrPwTE
CitedBy_id crossref_primary_10_1007_s12672_025_02151_9
crossref_primary_10_1515_oncologie_2024_0369
crossref_primary_10_1016_j_intimp_2024_113666
crossref_primary_10_3389_fimmu_2024_1469918
crossref_primary_10_2147_IJN_S508767
crossref_primary_10_3389_fimmu_2025_1568567
crossref_primary_10_1002_mco2_70116
crossref_primary_10_3389_fimmu_2024_1485174
crossref_primary_10_25259_Cytojournal_241_2024
Cites_doi 10.1038/onc.2017.184
10.1158/0008-5472.CAN-17-0994
10.1038/s41467-018-07582-3
10.1186/s13046-018-0941-x
10.1158/0008-5472.CAN-19-0819
10.21037/atm-21-2755
10.1038/s41418-019-0304-y
10.1158/1078-0432.CCR-17-2967
10.1016/j.biopha.2022.113446
10.1038/s43018-020-0082-y
10.1016/j.lfs.2020.118305
10.1016/j.cell.2018.01.009
10.1016/j.cell.2012.03.042
10.1016/j.neo.2021.05.004
10.1016/j.omtn.2020.05.033
10.1016/j.ajpath.2017.09.011
10.1261/rna.070177.118
10.1186/s12943-015-0426-x
10.3389/fimmu.2021.783362
10.1016/j.ebiom.2018.09.006
10.4149/neo_2020_200707N705
10.3389/fonc.2021.605884
10.1016/j.bbrc.2014.08.110
10.3349/ymj.2022.63.3.229
10.7150/thno.25541
10.1016/j.ebiom.2019.05.055
10.1016/j.biopha.2019.109623
10.1101/gad.276568.115
10.1016/j.cell.2017.09.021
10.1002/ijc.23611
10.1038/s41586-020-2623-z
10.1016/j.yexcr.2018.04.029
10.1186/1476-4598-12-168
10.7150/thno.19712
10.3389/froh.2021.686337
10.1016/j.ecoenv.2021.112376
10.1016/j.molonc.2014.04.009
10.1158/0008-5472.CAN-10-3228
10.1038/s41418-018-0242-0
10.1002/ijc.29464
10.1016/S0167-4889(00)00029-X
10.1038/s41419-020-02827-w
10.18632/oncotarget.3371
10.1186/s13046-021-02208-x
10.1042/BSR20130054
10.3390/cancers14235896
ContentType Journal Article
Copyright The Author(s) 2023
2023. The Author(s).
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2023
– notice: 2023. The Author(s).
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOA
DOI 10.1038/s41419-023-06280-3
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection (ProQuest)
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
CrossRef
Publicly Available Content Database
MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature Link OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ (Directory of Open Access Journals)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-4889
EndPage 13
ExternalDocumentID oai_doaj_org_article_b233851ff2d34fe9b22482c018fd5675
37993428
10_1038_s41419_023_06280_3
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Natural Science Foundation of China grants (81602382, 81972545)
– fundername: Natural Science Foundation of China grants (82170960)
GroupedDBID ---
0R~
3V.
53G
5VS
70F
7X7
88A
88I
8FE
8FH
8FI
8FJ
AAJSJ
ABUWG
ACGFS
ACSMW
ADBBV
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
E3Z
EBLON
EBS
EMOBN
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
HZ~
KQ8
LK8
M0L
M2P
M48
M7P
M~E
NAO
O5R
O5S
O9-
OK1
PIMPY
PQQKQ
PROAC
RNT
RPM
SNYQT
TR2
UKHRP
W2D
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AARCD
K9.
PKEHL
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
PUEGO
ID FETCH-LOGICAL-c485t-f1e050ba80d683e11c4b7c030bfdd96d3515d43e152cf7f0f09657c7dc22a8b03
IEDL.DBID M48
ISSN 2041-4889
IngestDate Wed Aug 27 01:23:55 EDT 2025
Wed Jul 30 10:53:12 EDT 2025
Wed Aug 13 08:09:39 EDT 2025
Mon Jul 21 05:39:51 EDT 2025
Tue Jul 01 03:50:11 EDT 2025
Thu Apr 24 22:55:22 EDT 2025
Fri Feb 21 02:36:59 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License 2023. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c485t-f1e050ba80d683e11c4b7c030bfdd96d3515d43e152cf7f0f09657c7dc22a8b03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4966-7119
0000-0002-8964-6232
0000-0001-7288-806X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41419-023-06280-3
PMID 37993428
PQID 2892418337
PQPubID 2041963
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_b233851ff2d34fe9b22482c018fd5675
proquest_miscellaneous_2892946692
proquest_journals_2892418337
pubmed_primary_37993428
crossref_primary_10_1038_s41419_023_06280_3
crossref_citationtrail_10_1038_s41419_023_06280_3
springer_journals_10_1038_s41419_023_06280_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-11-22
PublicationDateYYYYMMDD 2023-11-22
PublicationDate_xml – month: 11
  year: 2023
  text: 2023-11-22
  day: 22
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Cell death & disease
PublicationTitleAbbrev Cell Death Dis
PublicationTitleAlternate Cell Death Dis
PublicationYear 2023
Publisher Nature Publishing Group UK
Springer Nature B.V
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Springer Nature B.V
– name: Nature Publishing Group
References Lu, Xu, Lu (CR43) 2020; 260
Stockwell, Friedmann Angeli, Bayir, Bush, Conrad, Dixon (CR11) 2017; 171
Chen, Fu, Du, Zhao, Yang, Xu (CR21) 2020; 80
Conigliaro, Costa, Lo Dico, Saieva, Buccheri, Dieli (CR31) 2015; 14
Lu, Chan, Tan, Zhang, Guo, Xu (CR46) 2022; 41
Kawase, Ishii, Nagai, Ito, Nagano, Murata (CR15) 2008; 123
Bartoschek, Oskolkov, Bocci, Lovrot, Larsson, Sommarin (CR27) 2018; 9
Hoshino, Ishii, Ito, Aoyagi, Ohtaki, Nagai (CR17) 2011; 71
Neri, Ishii, Hashimoto, Kuwata, Nagai, Date (CR16) 2015; 137
CR38
Bienkowska, Hanley, Thomas (CR2) 2021; 2
Ruivo, Adem, Silva, Melo (CR3) 2017; 77
Li, Huang, Wen, Cui, Guo, He (CR24) 2019; 44
Amini Chermahini, Rashnonejad, Harper (CR18) 2019; 25
Sun, Hao, Zhuang, Lv, Liu, Su (CR30) 2022; 63
Yang, Qu, Li, Ma, Yu (CR23) 2022; 153
Takahashi, Ishii, Neri, Yoshida, Hashimoto, Suzuki (CR28) 2015; 6
Li, Dong, Cui, Wang, Hong (CR39) 2018; 37
Rasmussen, Helin (CR40) 2016; 30
Ding, Jia, Wang, Xu, Gao, Lu (CR9) 2019; 26
Ai, Wei, Wu, Tang, Li, Zou (CR22) 2021; 11
Li, Zhou, Gao (CR20) 2018; 369
Peng, Koirala, Mo (CR32) 2017; 36
Ren, Ding, Zhang, Shi, Xu, Shen (CR7) 2018; 8
Ubellacker, Tasdogan, Ramesh, Shen, Mitchell, Martin-Sandoval (CR25) 2020; 585
Bian, Zhang, Li, Feng, Wang, Zhang (CR34) 2018; 24
Wu, Pi, Chen, Zuo, Zhou, Ouyang (CR12) 2022; 2022
Friedman, Levi-Galibov, David, Bornstein, Giladi, Dadiani (CR26) 2020; 1
Fan, Zhou, Luo, Luo, Chen, Zhao (CR8) 2021; 23
Abdel-Fatah, Russell, Albarakati, Maloney, Dorjsuren, Rueda (CR36) 2014; 8
Zhang, Keymeulen, Nelson, Tong, Yuan, Yun (CR37) 2018; 188
Kim, Lee, Lee, Shin, Lee (CR35) 2000; 1496
Pan, Du, Liu, Cheng, Zhu, Jia (CR33) 2021; 9
Yang, Yang, Zhao, Chen, Xu, Fu (CR4) 2017; 7
Jia, Li, Pan, Tao, Wang, Lu (CR41) 2020; 22
CR45
Wang, Mao, Ouyang, Liu, Lai, Liu (CR13) 2019; 26
Niu, Yang, Liu, Fang (CR10) 2020; 121
Dixon, Lemberg, Lamprecht, Skouta, Zaitsev, Gleason (CR42) 2012; 149
Wu, Lu, Li, Ma, Long, Wu (CR44) 2021; 12
Li, Tao, Gao, Li, Zheng, Zhang (CR5) 2018; 36
Ma, Liang, Zhou, Wang (CR47) 2021; 68
Su, Chen, Yao, Liu, Yu, Lao (CR1) 2018; 172
Shindo, Aishima, Ohuchida, Fujiwara, Fujino, Mizuuchi (CR29) 2013; 12
Li, Zhou, Gao (CR19) 2014; 452
Dai, Jin, Han, Huang, Ji, Xu (CR6) 2020; 11
Zhang, Guo, Wang, Li, Hou, Li (CR14) 2021; 220
J Ren (6280_CR7) 2018; 8
CW Chen (6280_CR21) 2020; 80
CF Ruivo (6280_CR3) 2017; 77
Y Wu (6280_CR12) 2022; 2022
YY Li (6280_CR5) 2018; 36
X Ding (6280_CR9) 2019; 26
K Shindo (6280_CR29) 2013; 12
YY Li (6280_CR19) 2014; 452
Y Lu (6280_CR46) 2022; 41
KJ Bienkowska (6280_CR2) 2021; 2
JM Ubellacker (6280_CR25) 2020; 585
M Bartoschek (6280_CR27) 2018; 9
X Niu (6280_CR10) 2020; 121
G Amini Chermahini (6280_CR18) 2019; 25
YY Li (6280_CR20) 2018; 369
6280_CR45
Y Zhang (6280_CR14) 2021; 220
JT Fan (6280_CR8) 2021; 23
Y Ai (6280_CR22) 2021; 11
J Lu (6280_CR43) 2020; 260
Z Wu (6280_CR44) 2021; 12
A Takahashi (6280_CR28) 2015; 6
WW Yang (6280_CR4) 2017; 7
J Yang (6280_CR23) 2022; 153
A Hoshino (6280_CR17) 2011; 71
SJ Dixon (6280_CR42) 2012; 149
LL Ma (6280_CR47) 2021; 68
W Li (6280_CR24) 2019; 44
A Kawase (6280_CR15) 2008; 123
S Neri (6280_CR16) 2015; 137
IS Kim (6280_CR35) 2000; 1496
BR Stockwell (6280_CR11) 2017; 171
A Conigliaro (6280_CR31) 2015; 14
K Zhang (6280_CR37) 2018; 188
W Dai (6280_CR6) 2020; 11
Y Sun (6280_CR30) 2022; 63
S Su (6280_CR1) 2018; 172
WX Peng (6280_CR32) 2017; 36
M Jia (6280_CR41) 2020; 22
Z Bian (6280_CR34) 2018; 24
6280_CR38
Q Li (6280_CR39) 2018; 37
KD Rasmussen (6280_CR40) 2016; 30
M Wang (6280_CR13) 2019; 26
L Pan (6280_CR33) 2021; 9
G Friedman (6280_CR26) 2020; 1
TM Abdel-Fatah (6280_CR36) 2014; 8
References_xml – ident: CR45
– volume: 36
  start-page: 5661
  year: 2017
  end-page: 7
  ident: CR32
  article-title: LncRNA-mediated regulation of cell signaling in cancer
  publication-title: Oncogene
  doi: 10.1038/onc.2017.184
– volume: 77
  start-page: 6480
  year: 2017
  end-page: 8
  ident: CR3
  article-title: The biology of cancer exosomes: insights and new perspectives
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-0994
– volume: 9
  year: 2018
  ident: CR27
  article-title: Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-07582-3
– volume: 37
  start-page: 265
  year: 2018
  ident: CR39
  article-title: Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-018-0941-x
– volume: 80
  start-page: 2273
  year: 2020
  end-page: 85
  ident: CR21
  article-title: Long noncoding RNA MRPL23-AS1 promotes adenoid cystic carcinoma lung metastasis
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-19-0819
– volume: 9
  start-page: 1369
  year: 2021
  ident: CR33
  article-title: LncRNA FTX promotes the malignant progression of colorectal cancer by regulating the miR-214-5p-JAG1 axis
  publication-title: Ann Transl Med
  doi: 10.21037/atm-21-2755
– volume: 26
  start-page: 2329
  year: 2019
  end-page: 43
  ident: CR13
  article-title: Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA
  publication-title: Cell Death Differ
  doi: 10.1038/s41418-019-0304-y
– volume: 24
  start-page: 4808
  year: 2018
  end-page: 19
  ident: CR34
  article-title: LncRNA-FEZF1-AS1 promotes tumor proliferation and metastasis in colorectal cancer by regulating PKM2 signaling
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-17-2967
– volume: 153
  start-page: 113446
  year: 2022
  ident: CR23
  article-title: Biological role of long non-coding RNA FTX in cancer progression
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2022.113446
– volume: 1
  start-page: 692
  year: 2020
  end-page: 708
  ident: CR26
  article-title: Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4(+) and PDPN(+) CAFs to clinical outcome
  publication-title: Nat Cancer
  doi: 10.1038/s43018-020-0082-y
– volume: 260
  start-page: 118305
  year: 2020
  ident: CR43
  article-title: LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2020.118305
– volume: 172
  start-page: 841
  year: 2018
  end-page: 56
  ident: CR1
  article-title: CD10(+)GPR77(+) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness
  publication-title: Cell
  doi: 10.1016/j.cell.2018.01.009
– volume: 149
  start-page: 1060
  year: 2012
  end-page: 72
  ident: CR42
  article-title: Ferroptosis: an iron-dependent form of nonapoptotic cell death
  publication-title: Cell
  doi: 10.1016/j.cell.2012.03.042
– volume: 23
  start-page: 692
  year: 2021
  end-page: 703
  ident: CR8
  article-title: Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway
  publication-title: Neoplasia
  doi: 10.1016/j.neo.2021.05.004
– volume: 22
  start-page: 319
  year: 2020
  end-page: 28
  ident: CR41
  article-title: LINC-PINT suppresses the aggressiveness of thyroid cancer by downregulating miR-767-5p to induce TET2 expression
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1016/j.omtn.2020.05.033
– volume: 188
  start-page: 242
  year: 2018
  end-page: 51
  ident: CR37
  article-title: Overexpression of flap endonuclease 1 correlates with enhanced proliferation and poor prognosis of non-small-cell lung cancer
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2017.09.011
– volume: 25
  start-page: 1211
  year: 2019
  end-page: 7
  ident: CR18
  article-title: RNAscope in situ hybridization-based method for detecting DUX4 RNA expression in vitro
  publication-title: RNA
  doi: 10.1261/rna.070177.118
– volume: 14
  year: 2015
  ident: CR31
  article-title: CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA
  publication-title: Mol Cancer
  doi: 10.1186/s12943-015-0426-x
– volume: 12
  start-page: 783362
  year: 2021
  ident: CR44
  article-title: Identification and validation of ferroptosis-related LncRNA signatures as a novel prognostic model for colon cancer
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.783362
– volume: 36
  start-page: 209
  year: 2018
  end-page: 20
  ident: CR5
  article-title: Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2018.09.006
– volume: 68
  start-page: 165
  year: 2021
  end-page: 73
  ident: CR47
  article-title: Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4
  publication-title: Neoplasma
  doi: 10.4149/neo_2020_200707N705
– volume: 11
  start-page: 605884
  year: 2021
  ident: CR22
  article-title: Exosomal LncRNA LBX1-AS1 derived From RBPJ overexpressed-macrophages inhibits oral squamous cell carcinoma progress via miR-182-5p/FOXO3
  publication-title: Front Oncol
  doi: 10.3389/fonc.2021.605884
– volume: 452
  start-page: 490
  year: 2014
  end-page: 6
  ident: CR19
  article-title: Snail regulates the motility of oral cancer cells via RhoA/Cdc42/p-ERM pathway
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2014.08.110
– volume: 63
  start-page: 229
  year: 2022
  end-page: 40
  ident: CR30
  article-title: MEG3 LncRNA from exosomes released from cancer-associated fibroblasts enhances cisplatin chemoresistance in SCLC via a MiR-15a-5p/CCNE1 axis
  publication-title: Yonsei Med J
  doi: 10.3349/ymj.2022.63.3.229
– volume: 8
  start-page: 3932
  year: 2018
  end-page: 48
  ident: CR7
  article-title: Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19
  publication-title: Theranostics
  doi: 10.7150/thno.25541
– ident: CR38
– volume: 44
  start-page: 298
  year: 2019
  end-page: 310
  ident: CR24
  article-title: LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2019.05.055
– volume: 121
  start-page: 109623
  year: 2020
  ident: CR10
  article-title: LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2019.109623
– volume: 30
  start-page: 733
  year: 2016
  end-page: 50
  ident: CR40
  article-title: Role of TET enzymes in DNA methylation, development, and cancer
  publication-title: Genes Dev
  doi: 10.1101/gad.276568.115
– volume: 171
  start-page: 273
  year: 2017
  end-page: 85
  ident: CR11
  article-title: Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease
  publication-title: Cell
  doi: 10.1016/j.cell.2017.09.021
– volume: 123
  start-page: 1053
  year: 2008
  end-page: 9
  ident: CR15
  article-title: Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma
  publication-title: Int J Cancer
  doi: 10.1002/ijc.23611
– volume: 585
  start-page: 113
  year: 2020
  end-page: 8
  ident: CR25
  article-title: Lymph protects metastasizing melanoma cells from ferroptosis
  publication-title: Nature
  doi: 10.1038/s41586-020-2623-z
– volume: 369
  start-page: 43
  year: 2018
  end-page: 53
  ident: CR20
  article-title: Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-beta1 mediated by podoplanin
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2018.04.029
– volume: 12
  year: 2013
  ident: CR29
  article-title: Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-12-168
– volume: 7
  start-page: 3700
  year: 2017
  end-page: 14
  ident: CR4
  article-title: Epiregulin promotes lung metastasis of salivary adenoid cystic carcinoma
  publication-title: Theranostics
  doi: 10.7150/thno.19712
– volume: 2
  start-page: 686337
  year: 2021
  ident: CR2
  article-title: Cancer-associated fibroblasts in oral cancer: a current perspective on function and potential for therapeutic targeting
  publication-title: Front Oral Health
  doi: 10.3389/froh.2021.686337
– volume: 220
  start-page: 112376
  year: 2021
  ident: CR14
  article-title: LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p/SLC7A11 signaling
  publication-title: Ecotoxicol Environ Saf
  doi: 10.1016/j.ecoenv.2021.112376
– volume: 8
  start-page: 1326
  year: 2014
  end-page: 38
  ident: CR36
  article-title: Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer
  publication-title: Mol Oncol
  doi: 10.1016/j.molonc.2014.04.009
– volume: 71
  start-page: 4769
  year: 2011
  end-page: 79
  ident: CR17
  article-title: Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-3228
– volume: 26
  start-page: 1750
  year: 2019
  end-page: 65
  ident: CR9
  article-title: A DHX9-lncRNA-MDM2 interaction regulates cell invasion and angiogenesis of cervical cancer
  publication-title: Cell Death Differ
  doi: 10.1038/s41418-018-0242-0
– volume: 137
  start-page: 784
  year: 2015
  end-page: 96
  ident: CR16
  article-title: Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma
  publication-title: Int J Cancer
  doi: 10.1002/ijc.29464
– volume: 1496
  start-page: 333
  year: 2000
  end-page: 40
  ident: CR35
  article-title: Gene expression of flap endonuclease-1 during cell proliferation and differentiation
  publication-title: Biochim Biophys Acta
  doi: 10.1016/S0167-4889(00)00029-X
– volume: 11
  year: 2020
  ident: CR6
  article-title: Exosomal lncRNA DOCK9-AS2 derived from cancer stem cell-like cells activated Wnt/beta-catenin pathway to aggravate stemness, proliferation, migration, and invasion in papillary thyroid carcinoma
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-020-02827-w
– volume: 2022
  start-page: 6177553
  year: 2022
  ident: CR12
  article-title: Ginsenoside Rh4 inhibits colorectal cancer cell proliferation by inducing ferroptosis via autophagy activation
  publication-title: Evid Based Complement Altern Med
– volume: 6
  start-page: 9531
  year: 2015
  end-page: 41
  ident: CR28
  article-title: Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3371
– volume: 41
  start-page: 3
  year: 2022
  ident: CR46
  article-title: Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-021-02208-x
– volume: 14
  year: 2015
  ident: 6280_CR31
  publication-title: Mol Cancer
  doi: 10.1186/s12943-015-0426-x
– volume: 41
  start-page: 3
  year: 2022
  ident: 6280_CR46
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-021-02208-x
– volume: 7
  start-page: 3700
  year: 2017
  ident: 6280_CR4
  publication-title: Theranostics
  doi: 10.7150/thno.19712
– volume: 26
  start-page: 2329
  year: 2019
  ident: 6280_CR13
  publication-title: Cell Death Differ
  doi: 10.1038/s41418-019-0304-y
– volume: 452
  start-page: 490
  year: 2014
  ident: 6280_CR19
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2014.08.110
– volume: 8
  start-page: 3932
  year: 2018
  ident: 6280_CR7
  publication-title: Theranostics
  doi: 10.7150/thno.25541
– volume: 22
  start-page: 319
  year: 2020
  ident: 6280_CR41
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1016/j.omtn.2020.05.033
– volume: 36
  start-page: 209
  year: 2018
  ident: 6280_CR5
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2018.09.006
– volume: 71
  start-page: 4769
  year: 2011
  ident: 6280_CR17
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-3228
– volume: 2022
  start-page: 6177553
  year: 2022
  ident: 6280_CR12
  publication-title: Evid Based Complement Altern Med
– volume: 8
  start-page: 1326
  year: 2014
  ident: 6280_CR36
  publication-title: Mol Oncol
  doi: 10.1016/j.molonc.2014.04.009
– volume: 188
  start-page: 242
  year: 2018
  ident: 6280_CR37
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2017.09.011
– volume: 369
  start-page: 43
  year: 2018
  ident: 6280_CR20
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2018.04.029
– volume: 585
  start-page: 113
  year: 2020
  ident: 6280_CR25
  publication-title: Nature
  doi: 10.1038/s41586-020-2623-z
– volume: 153
  start-page: 113446
  year: 2022
  ident: 6280_CR23
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2022.113446
– volume: 11
  start-page: 605884
  year: 2021
  ident: 6280_CR22
  publication-title: Front Oncol
  doi: 10.3389/fonc.2021.605884
– volume: 12
  start-page: 783362
  year: 2021
  ident: 6280_CR44
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.783362
– volume: 26
  start-page: 1750
  year: 2019
  ident: 6280_CR9
  publication-title: Cell Death Differ
  doi: 10.1038/s41418-018-0242-0
– volume: 25
  start-page: 1211
  year: 2019
  ident: 6280_CR18
  publication-title: RNA
  doi: 10.1261/rna.070177.118
– volume: 37
  start-page: 265
  year: 2018
  ident: 6280_CR39
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-018-0941-x
– volume: 80
  start-page: 2273
  year: 2020
  ident: 6280_CR21
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-19-0819
– volume: 23
  start-page: 692
  year: 2021
  ident: 6280_CR8
  publication-title: Neoplasia
  doi: 10.1016/j.neo.2021.05.004
– volume: 44
  start-page: 298
  year: 2019
  ident: 6280_CR24
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2019.05.055
– volume: 63
  start-page: 229
  year: 2022
  ident: 6280_CR30
  publication-title: Yonsei Med J
  doi: 10.3349/ymj.2022.63.3.229
– volume: 6
  start-page: 9531
  year: 2015
  ident: 6280_CR28
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3371
– volume: 172
  start-page: 841
  year: 2018
  ident: 6280_CR1
  publication-title: Cell
  doi: 10.1016/j.cell.2018.01.009
– ident: 6280_CR38
  doi: 10.1042/BSR20130054
– volume: 149
  start-page: 1060
  year: 2012
  ident: 6280_CR42
  publication-title: Cell
  doi: 10.1016/j.cell.2012.03.042
– volume: 9
  year: 2018
  ident: 6280_CR27
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-07582-3
– volume: 24
  start-page: 4808
  year: 2018
  ident: 6280_CR34
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-17-2967
– volume: 137
  start-page: 784
  year: 2015
  ident: 6280_CR16
  publication-title: Int J Cancer
  doi: 10.1002/ijc.29464
– volume: 220
  start-page: 112376
  year: 2021
  ident: 6280_CR14
  publication-title: Ecotoxicol Environ Saf
  doi: 10.1016/j.ecoenv.2021.112376
– volume: 1496
  start-page: 333
  year: 2000
  ident: 6280_CR35
  publication-title: Biochim Biophys Acta
  doi: 10.1016/S0167-4889(00)00029-X
– volume: 9
  start-page: 1369
  year: 2021
  ident: 6280_CR33
  publication-title: Ann Transl Med
  doi: 10.21037/atm-21-2755
– volume: 1
  start-page: 692
  year: 2020
  ident: 6280_CR26
  publication-title: Nat Cancer
  doi: 10.1038/s43018-020-0082-y
– ident: 6280_CR45
  doi: 10.3390/cancers14235896
– volume: 11
  year: 2020
  ident: 6280_CR6
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-020-02827-w
– volume: 77
  start-page: 6480
  year: 2017
  ident: 6280_CR3
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-0994
– volume: 121
  start-page: 109623
  year: 2020
  ident: 6280_CR10
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2019.109623
– volume: 36
  start-page: 5661
  year: 2017
  ident: 6280_CR32
  publication-title: Oncogene
  doi: 10.1038/onc.2017.184
– volume: 68
  start-page: 165
  year: 2021
  ident: 6280_CR47
  publication-title: Neoplasma
  doi: 10.4149/neo_2020_200707N705
– volume: 171
  start-page: 273
  year: 2017
  ident: 6280_CR11
  publication-title: Cell
  doi: 10.1016/j.cell.2017.09.021
– volume: 12
  year: 2013
  ident: 6280_CR29
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-12-168
– volume: 2
  start-page: 686337
  year: 2021
  ident: 6280_CR2
  publication-title: Front Oral Health
  doi: 10.3389/froh.2021.686337
– volume: 123
  start-page: 1053
  year: 2008
  ident: 6280_CR15
  publication-title: Int J Cancer
  doi: 10.1002/ijc.23611
– volume: 30
  start-page: 733
  year: 2016
  ident: 6280_CR40
  publication-title: Genes Dev
  doi: 10.1101/gad.276568.115
– volume: 260
  start-page: 118305
  year: 2020
  ident: 6280_CR43
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2020.118305
SSID ssj0000330256
Score 2.4588668
Snippet Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer...
Abstract Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results...
SourceID doaj
proquest
pubmed
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 759
SubjectTerms 13/44
14
14/19
38
38/109
42
45/61
45/91
631/67/1536/1665
631/67/327
82
Antibodies
Biochemistry
Biomedical and Life Sciences
Cancer
Cancer-Associated Fibroblasts - metabolism
Carcinoma, Squamous Cell - pathology
Cell Biology
Cell Culture
Cell survival
Demethylation
Endonuclease
FEN1 protein
Ferroptosis
Ferroptosis - genetics
Fibroblasts
Fibroblasts - metabolism
Head and Neck Neoplasms - metabolism
Humans
Immunology
Invasiveness
Life Sciences
Membrane Glycoproteins - metabolism
Motility
Mouth Neoplasms - pathology
Non-coding RNA
Oral cancer
Oral carcinoma
Oral squamous cell carcinoma
RNA, Long Noncoding - genetics
RNA, Long Noncoding - metabolism
Squamous cell carcinoma
Squamous Cell Carcinoma of Head and Neck - pathology
Therapeutic targets
Tumor Microenvironment
Tumorigenesis
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuCMor0FZG4laixq_EOS5LVxUSSwWttDfLTxGpJNUmrdp_z9jJLkW8Llxj52HPjOebePwNQm9kIbz0OmaJe5Nz72VuakdzHak3SVlSn0qyfFyWJ-f8w0qs7pT6ijlhIz3wOHFHhkIQJUgI1DEefG3A50hqCyKDE4B24-oLPu9OMJXWYAjTwZlPp2QKJo96Tng8r0NjMQMqYfH5yRMlwv7focxfdkiT41k8Qg8nxIhn45c-Rvd8u4vujzUkb5-g7vT96fIQz2eLHgdtR9JtjwHX4ZhnF1E27gL-9GU-x_EvfY_NLW7ar41pYsYzDn697i6Hrm96fN1oPCQkG_kaodHfdH33Dd5-0drPyxlenK2eovPF8dn8JJ-qKOSWSzHkgfhCFEbLwpWSeUIsN5UF2zbBubp0DBCN49AgqA1VKELkg6ls5SylWpqCPUM7bdf6Fwh7UcuKmlLo2nItq9rUOpTGFtS5YEqeIbKZUWUnivFY6eJCpa1uJtUoBQVSUEkKimXocHvP5Uiw8dfe76Kgtj0jOXa6ACqjJpVR_1KZDO1txKwmi-0VBJ4AZiRjVYZeb5vB1qJodOu7q7FP5OOvaYaej-qx_RJWAdKDWC5Dbzf68uPhfx7Qy_8xoFfoAY2KTUhO6R7aGdZXfh-w0mAOkll8BwrTCsc
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k2gICNxK1Ed24mdE1oWVhUSSwWttDfLzxKpxMsmRfTf40myWyGg19hJnMyM_c14_A1CryUpvfQassS9ybn3Mje1o7kG6s2iqqgfSrJ8WlZHp_zjqlxNAbduSqvczonDRO2ihRj5YXIM0mIjGRNv1z9yqBoFu6tTCY2b6BZQl4FWi5XYxVhIctbTkj6dlSFMHna84HBqh0JJAyrTFPTHejTQ9v8La_61TzosP4t76O6EG_FsFPR9dMO3D9DtsZLk5UMUj98fLw_wfLbocNB2pN72OKE7DNl2gLVxDPjz1_kcQ6y-w-YSN-23xjSQ94yD32ziuo9d0-Gfjcb9gGeBtTE1-l-xi9_T289b-2U5w4uT1SN0uvhwMj_Kp1oKueWy7PNQeFISoyVxlWS-KCw3wiYLN8G5unIs4RrHU0NJbRCBBGCFEVY4S6mWhrDHaK-NrX-KsC9rKaipSl1brqWoTa1DZSyhzgVT8QwV2z-q7EQ0DvUuztWw4c2kGqWgkhTUIAXFMnSwu2c90mxc2_sdCGrXEyiyhwtxc6Ymi1OGJu-7LEKgjvHga5PAiqSWFDK4MrlJGdrfillNdtupKy3L0Ktdc7I4EI1ufbwY-wArf00z9GRUj91ImEh4L3l0GXqz1Zerh___g55dP5bn6A5UuYcjkJTuo71-c-FfJCzUm5eDwv8GKCgC9Q
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKKyQuiDeBgozErUQ4tpM4x7CwqlZiqWgr7c3yEyKVpNqkiP57xk6yCFGQuMZ2XjNjf2PPfIPQa0FyJ5wKUeJOp9w5kerK0lQF6s2sKKiLJVk-rovjc77a5Js9ROdcmBi0Hykt4zQ9R4e97XnGQ7oNDbUIqIC54xY6CFTtoNsHdb06Xe12Vgi46LCQTxkyhIkbBv-2CkWy_psQ5h-no3HRWd5Ddye0iOvx_e6jPdc-QLfH-pHXD1F38v5kfYQX9bLHXpmRcNthwHQ4xNgFhI07jz-dLhY47ND3WF_jpv3a6CZEO2Pvttvucuj6psffG4WHiGIDVyM0uh9d332Dp1-05vO6xsuzzSN0vvxwtjhOpwoKqeEiH1KfOZITrQSxhWAuywzXpQG71t7aqrAM0Izl0JBT40tPfOCCKU1pDaVKaMIeo_22a91ThF1eiZLqIleV4UqUla6UL7Qh1FqvC56gbP6j0kz04qHKxYWMx9xMyFEKEqQgoxQkS9DRbszlSK7xz97vgqB2PQMxdrzQbb_ISVGkpuBz55n31DLuXaUBoghqSCa8zcE5StDhLGY5WWsvwekEICMYKxP0atcMdhZEo1rXXY19Ahd_RRP0ZFSP3ZuwElAe-HEJejPry6-b__2Dnv1f9-foTqh1HxIhKT1E-8P2yr0ARDTol5MJ_ASKqwH8
  priority: 102
  providerName: Springer Nature
Title PDPN+ CAFs facilitate the motility of OSCC cells by inhibiting ferroptosis via transferring exosomal lncRNA FTX
URI https://link.springer.com/article/10.1038/s41419-023-06280-3
https://www.ncbi.nlm.nih.gov/pubmed/37993428
https://www.proquest.com/docview/2892418337
https://www.proquest.com/docview/2892946692
https://doaj.org/article/b233851ff2d34fe9b22482c018fd5675
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9NAEB71EKgviBtDiRaJt2Kw18euHxBKTaIqUkPUNlLeLO8FkVI7jVPUvPDbmfURkEh5sSXv-pwZzzf27vcBvOdepLnO7ShxLdxQa-6KRFE3t9SbfhxTXUuynI_js2k4mkWzPejkjtoHWO0s7aye1HS1-Hh3s_mCAf-5mTLOP1WhH9qpONTqFFCO75V9OMTMxKyiwXkL9-s3MxbvmOLbuTO7dz2ChwHDpB1affa_UlXN6L8Lhv7zC7XOTMPH8KiFlKTf-MAT2NPFU3jQiExunsFy8nUyJick7Q8rYnLZ0HJrgsiP2JF4FoeT0pBvl2lK7Hf8iogNmRc_5mJux0QTo1ercrkuq3lFfs5zsq6xrmV0xEZ9V1blNZ5-UciLcZ8Mr2bPYTocXKVnbquz4MqQR2vX-NqLPJFzT8U80L4vQ8EkRr8wSiWxChDzqBAbIioNM56xjDFMMiUpzbnwghdwUJSFfgVERwlnVMRRnsgw5ywRSW5iIT2qlBFx6IDfPdJMtiTkVgtjkdU_wwOeNRbJ0CJZbZEscOBku8-yoeD4b-9Ta6ltT0ufXW8oV9-zNhozQbEyj3xjqApCoxOBQIZT6fncqAhLKAeOOztnnUtmWJqiU_EgYA682zZjNFrT5IUub5s-lrE_oQ68bPxjeyWdWznwoXOYPwe__4Ze33ugN3BEref6vkvpMRysV7f6LUKktejBPpuxHhz2-6PLEa5PB-PJBW5N47RXf3bo1ZFhl78GvwHgAQ0q
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYIL4k2ggJHgVKI6dh7OAaFly2pL26WCrbQ3N35BpJIsmxTYP8VvxJNXhYDeeo0dx_GMPd_Y4_kQesFJZLjJIErcSD80hvsy1dTPIPVmEMfUNJQsh7N4ehy-X0SLDfSrvwsDYZX9mtgs1LpUsEe-4xwDZ2w4Y8mb5TcfWKPgdLWn0GjVYt-sfziXrXq9t-vk-5LSybv5eOp3rAK-CnlU-zYwJCIy40THnJkgUKFMlNN1abVOY82chdehK4iosoklFvKjJCrRitKMS8Jcu1fQVWd4CTh7ySIZ9nQIYwAhurs5hPGdKgxCuCVEgUKBcrfk_WH_GpqAf2Hbv85lG3M3uYVudjgVj1rFuo02THEHXWuZK9d3UXm0ezTbxuPRpMI2U22qb4MdmsQQ3QfYHpcWf_g0HmM4G6iwXOO8-JLLHOKssTWrVbmsyyqv8Pc8w3WDnyFLpCs0P8uq_Oq-flqoj7MRnswX99DxpYzyfbRZlIV5iLCJUp5QGUdZqsKMJ6lMMxtLRajWVsahh4J-RIXqEpsDv8apaA7YGRetFISTgmikIJiHtod3lm1ajwtrvwVBDTUhJXfzoFx9Ft0MF5I6bz8KrKWahdak0oEjThUJuNWRc8s8tNWLWXTrRCXOtdpDz4diN8NBNFlhyrO2DrAApNRDD1r1GHrCEocvnQfpoVe9vpw3_v8fenRxX56h69P54YE42JvtP0Y3KKhvEPiUbqHNenVmnjgcVsunjfJjdHLZs-03VmM_0A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrUBcEG8CBYwEpxJtYufhHBDa7nbVUlhWpZX25sYvWKkkZbMF9q_x6_DksRUCeus1dhzHM7a_8YznA3jJg9hwk2OUuJF-ZAz3Zaapn2PqzTBJqKkpWT5Mkr3j6N0snm3Ar-4uDIZVdmtivVDrUuEZed8ZBm6z4YylfduGRUxH47dn33xkkEJPa0en0ajIgVn9cOZb9WZ_5GT9itLx7tFwz28ZBnwV8Xjp29AEcSBzHuiEMxOGKpKpcnovrdZZopnb7XXkCmKqbGoDi7lSUpVqRWnOZcBcu9dgM0WrqAebO7uT6eH6hCdgDAFFe1MnYLxfRWGEd4YoEipQ7hbAP3bDmjTgX0j3Ly9tvfmNb8OtFrWSQaNmd2DDFHfhesNjuboH5XQ0nWyT4WBcEZurJvG3IQ5bEoz1Q6RPSks-fhoOCXoKKiJXZF58mcs5Rl0TaxaL8mxZVvOKfJ_nZFmjacwZ6QrNz7Iqv7qvnxbqcDIg46PZfTi-knF-AL2iLMwjICbOeEplEueZinKeZjLLbSJVQLW2Mok8CLsRFapNc45sG6eidrczLhopCCcFUUtBMA-21--cNUk-Lq29g4Ja18QE3fWDcvFZtPNdSOps_zi0lmoWWZNJB5U4VUHIrY6dkebBVidm0a4albjQcQ9erIvdfEfR5IUpz5s6yAmQUQ8eNuqx7glLHdp09qQHrzt9uWj8_z_0-PK-PIcbbqaJ9_uTgydwk6L2hqFP6Rb0lotz89SBsqV81mo_gZOrnnC_AfjcRWs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PDPN+%2B+CAFs+facilitate+the+motility+of+OSCC+cells+by+inhibiting+ferroptosis+via+transferring+exosomal+lncRNA+FTX&rft.jtitle=Cell+death+%26+disease&rft.au=Li%2C+Yaoyin&rft.au=Ma%2C+Zeyi&rft.au=Li%2C+Weiyu&rft.au=Xu%2C+Xiaoqing&rft.date=2023-11-22&rft.eissn=2041-4889&rft.volume=14&rft.issue=11&rft.spage=759&rft_id=info:doi/10.1038%2Fs41419-023-06280-3&rft_id=info%3Apmid%2F37993428&rft.externalDocID=37993428
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon